Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 13 Nov 2009):

Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.

Full Abstract

Death receptors of the tumor necrosis factor (TNF) receptor super family have been implicated in constitutive activation of nuclear factor-kappa B (NF-kappaB) in pancreatic cancer (PaC) cells. In this study, we demonstrate that fisetin, a natural flavonoid, induces apoptosis and inhibits invasion of chemoresistant PaC AsPC-1 cells through suppression of DR3-mediated NF-kappaB activation. Fisetin treatment resulted in dose-dependent inhibition of PaC cell growth and cell proliferation with concomitant induction of apoptosis. A cDNA array analysis revealed that fisetin modulates expression of more than 20 genes at transcription level with maximum decrease observed in DR3 expression and a parallel increase observed in the expression levels of IkappaBalpha, an NF-kappaB inhibitor. Down-regulation of DR3 in PaC cells was found to down regulate activated pNF-kappaB/p65, pIkBalpha/beta kinases (pIKK's), MMP9 and XIAP that mostly impart chemoresistance in PaC. Immunoblotting and EMSA analysis showed a marked decrease in pNF-kappaB and NF-kappaB DNA binding activity, respectively, with modest decrease in NF-kappaB promoter activity and significant decrease in MMP9 promoter activity with fisetin treatment. Importantly, consistent with these findings, we further found that transient down-regulation of DR3 by RNA interference significantly augmented fisetin induced changes in cell proliferation, cell invasion and apoptosis paralleled with decrease in pNF-kappaB, pIKKalpha/beta, MMP9, XIAP and NF-kappaB DNA binding activity. Blocking of DR3 receptor with an extra cellular domain blocking antibody demonstrated similar effects. These data provide evidence that fisetin could provide a biological rationale for treatment of pancreatic cancer or as an adjuvant with conventional therapeutic regimens.

 

Author information

Author/s: Murtaza, Imtiyaz (I); Adhami, Vaqar Mustafa (VM); Hafeez, Bilal Bin (BB); Saleem, Mohammad (M); Mukhtar, Hasan (H);

Affiliation: Department of Dermatology, University of Wisconsin, Madison, WI 53706, USA. imz007(-atsign-)rediffmail.com

Grants: R01CA101039 (Agency:NCI NIH HHS) ; R01CA120451 (Agency:NCI NIH HHS) ; R01CA78809 (Agency:NCI NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal: International journal of cancer. Journal international du cancer (Int J Cancer), published in United States. (Language: eng)

Reference: 2009-Nov; vol 125 (issue 10) : pp 2465-73

Dates: Created 2009/09/28; Completed 2009/11/05;

PMID: 19670328, status: MEDLINE (last retrieval date: 11/5/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Flavonoids (0) ; I-kappa B Proteins (0) ; NF-kappa B (0) ; RNA, Small Interfering (0) ; Receptors, Tumor Necrosis Factor, Member 25 (0) ; TNFRSF25 protein, human (0) ; X-Linked Inhibitor of Apoptosis Protein (0) ; XIAP protein, human (0) ; NF-kappaB inhibitor alpha (139874-52-5) ; fisetin (528-48-3) ; Matrix Metalloproteinase 9 (EC 3.4.24.35)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

4/29/1999
6/19/2008
Higher Relevance Score (100)
Lower Relevance Score (72)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index